RESUMEN
BACKGROUND: Human erythrovirus B19, endemic in the Amazon region since 1990, is associated with a wide spectrum of clinical presentations. OBJECTIVES: To assess the prevalence of erythrovirus B19 infection and the relative frequency of erythrovirus B19 genotypes in patients in the Amazon region with various clinical presentations. STUDY DESIGN: A total of 487 clinical samples obtained from patients with symptoms suggestive of erythrovirus infection were tested using specific IgM and IgG antibody assays (ELISA) and PCR for viral DNA detection. Partial VP1 and VP2 regions were sequenced and genotyped by phylogenetic reconstruction. RESULTS: B19 DNA was detected in 117 (24%) of 487 samples. Of these, 106 (91%) isolates were genotype 1 and 11 (9%) were genotype 3. No genotype 2 was found. Genotype 1 had three clusters (A1, A2 and B) and all genotype 3 sequences were subtype 3b. All patients with hematological disorders within cluster B of genotype 1 were infected by the same B19 lineage, suggesting that this lineage of B19 may have been transmitted via transfusion of blood products. CONCLUSION: We reported two genotypes, 1 and 3b, with three genotype 1 clusters co-circulating in the Amazon region during the past 10 years.
Asunto(s)
Infecciones por Parvoviridae/virología , Parvovirus B19 Humano/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Teorema de Bayes , Brasil/epidemiología , Niño , Preescolar , ADN Viral/genética , Femenino , Genotipo , Humanos , Lactante , Masculino , Persona de Mediana Edad , Infecciones por Parvoviridae/epidemiología , Filogenia , Reacción en Cadena de la PolimerasaRESUMEN
Serum samples from 497 children and adults inhabiting two neighbourhoods (Guamá and Terra Firme) in Belém, Pará, North Brazil were screened for the presence of human herpesvirus 8 (HHV-8) antibody using an enzyme-linked immunosorbent assay. An overall 16.3% prevalence was found for these urban communities. Taken both genders together, prevalence rates of HHV-8 antibody increase gradually, across age-groups, ranging from 12.0% to 33.3%. When seroprevalence is analysed by gender, similar rates are found for female (18.4%) and male (14.0%) individuals. In the former gender group, seroprevalence rates increased from 10.3%, in children < or = 10 years of age, to 30.0% in adults 41-50 years of age. Conversely, among male subjects, the prevalence of HHV-8 antibodies decreased from 13.3% in children/young adults aged < or = 10 to 20 years of age to 6.1% in adults aged 21-30 years. From the 31-40 year-old group male onwards, seropositivity rates increased gradually, ranging from 8.3% to 66.7%. A significant difference in seropositivity rates was noted when comparing 21-30 age groups for female and male subjects: 23.3% and 6.1%, respectively (P = 0.03). Geometric mean optical densities were found to increase slightly from the lower to the higher age-groups. Our data suggest that transmission of HHV-8 occurs frequently in the general urban population of Belém, and that prevalence of antibody seems to increase with age.
Asunto(s)
Anticuerpos Antivirales/aislamiento & purificación , Infecciones por Herpesviridae/inmunología , Herpesvirus Humano 8/inmunología , Adolescente , Adulto , Anciano , Brasil/epidemiología , Niño , Preescolar , Femenino , Infecciones por Herpesviridae/epidemiología , Humanos , Lactante , Masculino , Tamizaje Masivo , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Estudios Seroepidemiológicos , Población UrbanaRESUMEN
A total of 323 patients with lymphadenopathy were selected in Belém, Brazil, between January 1996 and December 2001, and screened for the presence of human herpesvirus-6 (HHV-6) IgM- and--IgG antibodies by enzyme-linked immunosorbent assay (ELISA). When seroprevalence is analyzed by gender, similar rates are found for female (60.6%) and male (55.7%) individuals. Seventy-seven (23.8%) patients were HHV-6-IgM-and--IgG-positive (IgM+ subgroup), with positivity rates of 29.7% and 17.7% (p = 0.0007) for female- and male individuals, respectively. Sera from a subgroup (n = 120) of these subjects, with high HHV-6 antibody levels (either IgM+ or IgG+ reactivities), were subsequently processed for the presence of HHV-6 DNA by polymerase chain reaction (PCR)/nested PCR. Active infections (IgM+ and/or IgG+ high levels specific antibodies plus detection of viral DNA) were diagnosed in 20/77 (20.0%) and 8/43 (18.6%); subgroup of the 120 individuals suspected of having HHV-6 suggestive recent infection. All (n = 28) cases of active infection were found to be associated with HHV-6 variant-A (HHV-6A), as detectable by PCR/nested PCR, using variant-specific primer that amplify regions of 195 base pairs (bp) (HHV-6A) and 423 bp (HHV-6B). Rates of HHV-6 DNA detection between female and male patients were similar (p > 0.05) in the IgM+ and IgG+ groups: 20.4% versus 35.7% and 25.0% versus 13.0%, respectively. HHV-6 DNA was detected across < or = 5 through 41-50-year age-groups for patients whose serum samples were IgM+, with rates ranging from 7.7% (female subjects aged < or = 5 years) to 80.0% (male, 11-20 years). Among patients whose serological status was IgG+, HHV-6 DNA was detected in < or = 5, 6-10, 21-30 and > 50 age-groups at rates that ranged from 15.4% (male, < or = years of age) to 100.0% (female aged 11-20 years). Swelling cervical lymph nodes were the most common sign, accounting for 9 (32.0%) cases in each gender group. Among patients (n = 28) with active infection by HHV-6A variant, duration of symptoms lasted 1-5 days in 35.7% of subjects, whereas in 64.3% of them the disease lasted 6-20 days. Our data suggest that it is worth seeking for HHV-6 infection whenever a patient (infant or adult) presents with lymphadenopathy as a prominent symptom in the course of an acute febrile illness.
Asunto(s)
Anticuerpos Antivirales/sangre , Infecciones por Herpesviridae/virología , Herpesvirus Humano 6/inmunología , Enfermedades Linfáticas/virología , Adolescente , Adulto , Anciano , Antígenos Virales/inmunología , Brasil/epidemiología , Niño , Preescolar , ADN Viral/análisis , Ensayo de Inmunoadsorción Enzimática , Femenino , Infecciones por Herpesviridae/diagnóstico , Infecciones por Herpesviridae/epidemiología , Herpesvirus Humano 6/genética , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Lactante , Enfermedades Linfáticas/diagnóstico , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Prevalencia , Estudios RetrospectivosRESUMEN
A total of 220 patients with arthropathy were selected in Belém, Pará between January 1994 and December 2000, and screened for the presence of human parvovirus B19 IgM and IgG antibodies by enzyme-linked immunosorbent assay (ELISA). A subgroup (n = 132) of patients with high levels of antibodies (either IgM+/IgG+ or IgM-/IgG+) were examined for the presence of DNA by polymerase chain reaction/nested PCR. Recent/active infection (detection of IgM and/or IgG-specific antibodies and presence of viral DNA) was identified in 47.7% of the 132 individuals with arthropathy. In our study, women were significantly more affected (59.7%) than men (35.4%) (P = 0.0006). The age group of 11-20 years (84.6%), among female patients, and 21-30 years (42.1%), among male, were those with the highest incidence rates. The analysis of the temporal distribution of B19-associated arthropaties showed a cyclic pattern, with peak incidence rates occuring at 3-5 year intervals. Significant diference (P = 0.01) was observed when comparing both the highest (39.0%) and the lowest (11.0%) seropositivity rates for the years of 1995 and 2000, respectively. The interfalangial joints of hands and feet were mostly affected, with 50.0% and 48.0% of cases among both women and men, respectively. In a smaller proportion, other joints such as those of knee, ankle, pulse and shoulder were affected. As for the duration, symptoms lasted 1 to 5 days in 54.0% of the individuals, whereas in 46.0% of them the disease lasted 6-10 days, if considered the subgroup (n = 63) of patients with recent/active infection by parvovirus B19. In our study, joint clinical manifestations occurred symmetrically. Our results indicate that B19 may be an important agent of arthropathies in our region, and this underscores the need for specific laboratory diagnosis when treating patients suffering from acute arthropathy, mainly pregnant women.
Asunto(s)
Anticuerpos Antivirales/sangre , Artropatías/virología , Infecciones por Parvoviridae/complicaciones , Parvovirus B19 Humano/inmunología , Adolescente , Adulto , Brasil/epidemiología , Niño , ADN Viral/sangre , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Artropatías/sangre , Artropatías/epidemiología , Masculino , Infecciones por Parvoviridae/sangre , Reacción en Cadena de la Polimerasa , Sensibilidad y EspecificidadRESUMEN
We screened sera from 370 patients suffering from exanthematous illnesses in Belém, North Brazil, for the presence of human herpesvirus-7 (HHV-7) IgM and IgG antibodies. Samples were obtained from January 1996 to December 2002 and were processed by a HHV-7-specific indirect immunofluorescence assay (IFA). HHV-7-specific IgM and/or IgG antibodies were found in 190 (51.4%) of these patients, with similar prevalence rates (IgM+ and IgG+ subgroups taken together) for female and male subjects: 52.5% and 50.3%, respectively. Serological status as defined by IgG was identified in 135 (36.5%) patients. In 55 (14.9%) of the patients HHV-7 IgM antibodies were detected. HHV-7 IgM- and- IgG antibody rates were similar (p > 0.05) when male and female subjects are compared: 14.4% versus 15.3% and 38.1% versus 35.0%, respectively. Statistically significant difference (p = 0.003) was noted when HHV-7-IgM-positive female and male patients aged 5-8 months are compared. Prevalence rates ranging from 4.6% (female, 5-8 months of age) to 93.3% (female, > 10 years of age) and 12.2% (male, 5-8 months) to 80.0% (male, 8-10 years of age) were noted in the IgG- positive subgroups. A subgroup (n = 131) of patients with IgM or IgG HHV-7 antibodies were examined for the presence of DNA using a polymerase chain reaction/nested PCR. Recent/active HHV-7 infection occurred at a rate of 11.0% (6/55) among patients whose samples presented IgM+ specific antibodies. In a subgroup (n = 76) of patients with high HHV-7-IgG antibody levels (titre > 1:160) DNA could not be detected in sera examined by PCR/nested PCR. Of the six recent/active infections, four subjects with less than 1 year and two with 3 and 6 years of age, presented typical exanthem subitum (E.S), as defined by higher fever (> 38.0 degrees C) with duration of 24 to 72 hours, followed by a maculopapular skin rash. Our results underscore the need for searching HHV-7 infection in patients with exanthematous diseases, particularly those presenting with typical E.S. HHV-7 appears therefore to emerge as a newly recognized pathogen of exanthem in our region.
Asunto(s)
Anticuerpos Antivirales/sangre , Exantema/virología , Herpesvirus Humano 7/aislamiento & purificación , Infecciones por Roseolovirus/virología , Adolescente , Adulto , Distribución por Edad , Anciano , Brasil/epidemiología , Niño , Preescolar , Exantema/epidemiología , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Herpesvirus Humano 7/inmunología , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Lactante , Masculino , Persona de Mediana Edad , Infecciones por Roseolovirus/epidemiología , Estudios Seroepidemiológicos , Distribución por SexoRESUMEN
The rhesus-human reassortant, tetravalent rotavirus vaccine (RRV-TV) was licensed for routine use in the United States of America but it was recently withdrawn from the market because of its possible association with intussusception as an adverse event. The protective efficacy of 3 doses of RRV-TV, in its lower-titer (4 x 10(4) pfu/dose) formulation, was evaluated according to the nutritional status of infants who participated in a phase III trial in Belém, Northern Brazil. A moderate protection conferred by RRV-TV was related to weight-for-age Z-scores (WAZ) greater than -1 only, with rates of 38% (p = 0.04) and 40% (p = 0.04) for all- and- pure rotavirus diarrhoeal cases, respectively. In addition, there was a trend for greater efficacy (43%, p = 0.05) among infants reaching an height-for-age Z-score (HAZ) of > -1. Taking WAZ, HAZ and weight-for-height Z-score (WHZ) indices = -1 together, there was no significant protection (p > 0.05) if both placebo and vaccine groups are compared. There was no significant difference if rates of mixed and pure rotavirus diarrhoeal cases are compared in relation to HAZ, WAZ and weight-for-height Z-score (WHZ) indices. Although a low number of malnourished infants could be identified in the present study, our data show some evidence that malnutrition may interfere with the efficacy of rotavirus vaccines in developing countries.
Asunto(s)
Estado Nutricional , Infecciones por Rotavirus/prevención & control , Vacunas contra Rotavirus/uso terapéutico , Rotavirus/inmunología , Animales , Antropometría , Brasil , Países Desarrollados , Diarrea/prevención & control , Diarrea/virología , Método Doble Ciego , Gastroenteritis/prevención & control , Gastroenteritis/virología , Humanos , Lactante , Recién Nacido , Virus Reordenados/inmunología , Vacunas Atenuadas/uso terapéuticoRESUMEN
Group A rotaviruses are the most important agents of severe diarrhea in children and infants worldwide. The aim of present study was to identify rotavirus G serotypes and P[],G genotypes in cases of reinfection among children who participated in a vaccine trial with the tetravalent rhesus-human reassortant rotavirus vaccine (RRV-TV 4 x 10(4) pfu/dose) in Belém, Brazil. From July 1990 to June 1992, 540 children received, at their first, third and fifth months of life, oral doses of either vaccine or placebo. A total of 90 rotavirus diarrheal episodes among children who completed the three-dose vaccination schedule were recorded. We studied 11 reinfection rotavirus cases among five children (three female and two male). Fecal specimens were tested by using a enzyme immunoassay (IDEIA Rotavirus), followed by EIA with monoclonal antibodies to determine infecting serotypes Gl, G2, G3 and G4 and subgroups I and II. The viral dsRNA was extracted and electrophoresed through polyacrylamide gel and then subjected to reverse-transcription-polymerase chain reaction and nested-PCR for the determination of Gl, G2, G3, G4, G5 and G9 and P[4], P[6], P[8] and P[9] rotavirus genotypes. A total of 11 cases of reinfection (12 per cent) occurred among five children, three from the placebo group and two from the vaccine group. In four of the cases of reinfection G serotypes and P[],G genotypes were as follows: for the first and second infections, respectively: (1) G2/P[4],G2 and Gl/P[4],G1; (2) G2/P[4],G2 and G2/P[6],G5; (3) G2/P[4],G2 and G1/P[8],G1; and (4) G2/P[8],G1 and G1/P[8],G1. A fifth child had three successive infections caused by serotypes/genotypes G1/P[8],G1, in the first and second infections, and G2/P[4],G2 in the third infection. The common genotypes and unusual genotypes were detected in 8 (73 per cent) and 3 (27 per cent) of the isolates, respectively. With regards to the clinical severity, in two children a score indicated moderate/severe disease in both first and second infections. One child had three successive infections; the first episode was moderate/severe, the second very severe and the third was not available. In contrast, in two other children, the first episode was very severe, and the second episode was moderate/severe in one child and data was not available for the other child. The results obtained in the present investigation underscore the need to broaden our knowledge of the immunity in rotavirus reinfection. This should be useful regarding future rotavirus vaccination strategies in Brazil.
Asunto(s)
Diarrea/virología , Infecciones por Rotavirus/virología , Rotavirus/aislamiento & purificación , Brasil/epidemiología , Preescolar , Diarrea/epidemiología , Diarrea/prevención & control , Heces/virología , Femenino , Genotipo , Humanos , Técnicas para Inmunoenzimas/métodos , Lactante , Masculino , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Rotavirus/clasificación , Rotavirus/genética , Infecciones por Rotavirus/epidemiología , Infecciones por Rotavirus/prevención & control , Vacunas contra Rotavirus/uso terapéuticoRESUMEN
Serum samples from 497 children and adults inhabiting two neighbourhoods (Guamß and Terra Firme) in BelÚm, Parß, North Brazil were screened for the presence of human herpesvirus 8 (HHV-8) antibody using an enzyme-linked immunosorbent assay. An overall 16.3 percent prevalence was found for these urban communities. Taken both genders together, prevalence rates of HHV-8 antibody increase gradually, across age-groups, ranging from 12.0 percent to 33.3 percent. When seroprevalence is analysed by gender, similar rates are found for female (18.4 percent) and male (14.0 percent) individuals. In the former gender group, seroprevalence rates increased from 10.3 percent, in children ú 10 years of age, to 30.0 percent in adults 41-50 years of age. Conversely, among male subjects, the prevalence of HHV-8 antibodies decreased from 13.3 percent in children/young adults aged ú 10 to 20 years of age to 6.1 percent in adults aged 21-30 years. From the 31-40 year-old group male onwards, seropositivity rates increased gradually, ranging from 8.3 percent to 66.7 percent. A significant difference in seropositivity rates was noted when comparing 21-30 age groups for female and male subjects: 23.3 percent and 6.1 percent, respectively (P = 0.03). Geometric mean optical densities were found to increase slightly from the lower to the higher age-groups. Our data suggest that transmission of HHV-8 occurs frequently in the general urban population of BelÚm, and that prevalence of antibody seems to increase with age
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Anticuerpos Antivirales , Infecciones por Herpesviridae , Herpesvirus Humano 8 , Brasil , Tamizaje Masivo , Prevalencia , Factores de Riesgo , Estudios Seroepidemiológicos , Población UrbanaRESUMEN
Um total de 323 pacientes apresentando linfadenopatia foi selecionado em Belém, Pará, Brasil, entre janeiro de 1996 a dezembro de 2001 e, posteriormente, examinado quanto à presença de anticorpos IgM e IgG para o herpesvírus 6 (HHV-6), utilizando-se a técnica imunoenzimática (ELISA). Taxas similares são encontradas quando a soroprevalência é analisada nos indivíduos do sexo feminino (60,6 por cento) e masculino (55,7 por cento). Setenta e sete (23,8 por cento) pacientes apresentaram anticorpos IgM e IgG para o HHV-6 (subgrupo IgM+), com taxas de positividade de 29,7 por cento e 17,7 por cento (p = 0,0007) para indivíduos dos sexos feminino e masculino, respectivamente. Soros de um subgrupo (n = 120) desses indivíduos, com altos níveis de anticorpos IgM+ ou IgG+, foram subseqüentemente processados para detecção do DNA viral do HHV-6, através da reação em cadeia da polimerase (PCR) e do "nested" PCR. Infecções ativas (detecção de altos níveis de anticorpos IgM+ e/ou IgG+ específicos mais a presença de DNA viral) foram diagnosticadas em 20/77 (26,0 por cento) e 8/43 (18,6 por cento); subgrupo de 120 indivíduos com quadro sugestivo de infecção recente por HHV-6. Todos (n = 28) os casos de infecção ativa foram associados com variante A do HHV-6 (HHV-6A), detectada pela técnica de PCR/"nested" PCR, utilizando-se "primers" específicos que amplificam regiões de 195 pares de bases (pb) (HHV-6A) e 423 pb (HHV-6B).Taxas de detecção do DNA do HHV-6 foram similares (p > 0,05) em pacientes dos sexos feminino e masculino, no grupo IgM+ e IgG+ com: 20,4 por cento versus 35,7 por cento e 25,0 por cento versus 13,0 por cento, respectivamente. A detecção do DNA viral do HHV-6 ocorreu no grupo etário < 5 até o de 41-50 anos, nos pacientes cujas amostras de soro apresentaram presença de IgM+, com taxas variando de 7,7 por cento (mulheres do grupo < 5 anos) a 80,0 por cento (homens, 11-20 anos). Acerca dos pacientes cujo "status" sorológico foi IgG+, o DNA do HHV-6 foi detectado nos grupos de < 5, 6-10, 21-30 e > 50 anos, com taxas que variaram de 15,4 por cento (homens, < 5 anos) a 100,0 por cento (mulheres, 11-20 anos). O aumento dos linfonodos cervicais foi registrado como mais freqüente, ocorrendo em número de 9 (32,0 por cento) casos, tanto entre indivíduos do sexo masculino como naqueles do feminino. Entre os pacientes (n = 28) com infecção ativa pela variante A do HHV-6, a duração dos sintomas em 35,7 por cento deles foi de 1-5 dias, enquanto em 64,3 por cento...
Asunto(s)
Adolescente , Persona de Mediana Edad , Humanos , Masculino , Femenino , Lactante , Niño , Preescolar , Adulto , Anticuerpos Antivirales , Infecciones por Herpesviridae , Herpesvirus Humano 6 , Enfermedades Linfáticas , Antígenos Virales , Brasil , ADN Viral , Ensayo de Inmunoadsorción Enzimática , Infecciones por Herpesviridae , Herpesvirus Humano 6 , Enfermedades Linfáticas , Reacción en Cadena de la Polimerasa , Prevalencia , Estudios RetrospectivosRESUMEN
Examinamos soros de 370 pacientes acometidos de doença exantemática, selecionados em Belém, norte do Brasil, com o propósito de se detectarem anticorpos IgM e IgG para o herpesvírus humano-7 (HHV-7). As amostras foram obtidas entre janeiro de 1996 e dezembro de 2002 e, posteriormente, processadas utilizando-se a técnica da imunofluorescência indireta (IFI). Taxas de anticorpos IgM e/ou IgG foram encontradas em 190 (51,4) desses pacientes. Observamos taxas de prevalência similares para os sexos feminino e masculino com: 52,5 e 50,3, respectivamente. O "status" sorológico foi definido pela presença de anticorpos IgG nos espécimes de 135 (36,5) pacientes. A par disso, em 55 (14,9) dos 370 pacientes foram detectados anticorpos IgM para o HHV-7. Taxas de anticorpos IgM e IgG para o HHV-7 foram similares (p > 0.05) quando comparamos indivíduos do sexo feminino e masculino: 14,4 versus 15,3 e 38,1 versus 35,0, respectivamente. Diferença estatisticamente significativa (p = 0,003) foi observada quando comparamos as taxas de anticorpos IgM para o HHV-7 nos indivíduos do grupo etário de 5-8 meses pertencentes ao sexo feminino e masculino. Taxas de prevalência variando de 4,6 (masculino, 5-8 meses de idade) a 93,3 (feminino, > 10 anos de idade) e 12,2 (masculino, 5-8 meses de idade) a 80,0 (masculino, 8-10 anos de idade) foram observadas no subgrupo positivo para IgG. Um subgrupo (n = 131) de pacientes com anticorpos IgM ou IgG foi examinado quanto a presença de DNA para o HHV-7 pela técnica da reação em cadeia da polimerase/ "nested" PCR. Infecção recente/ativa para o HHV-7 ocorreu em 11,0 (6/55) dos pacientes cujas amostras apresentaram anticorpos IgM específicos para o HHV-7. Em um subgrupo (n = 76) de pacientes com altos níveis de anticorpos IgG para o HHV-7 (título > 1: 160) não foi detectada a presença de DNA em seus soros pelo PCR/ "nested" PCR. Entre as seis infecções recentes/ativas, quatro indivíduos com menos de um ano e dois com 3 e 6 anos de idade apresentaram típico exantema súbito (E.S) definido por febre elevada (> 38,0 ºC) com duração de 24 a 72 horas, acompanhando-se de erupção cutânea maculopapular. Nossos resultados ressaltam a necessidade de procurarmos a infecção pelo HHV-7 em pacientes portadores de doença exantemática, particularmente naquelas apresentações típicas de E.S. O HHV-7 parece emergir como um novo patógeno associado a quadros exantemáticos em nossa região.
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Anticuerpos Antivirales , Exantema , Herpesvirus Humano 7 , Infecciones por Roseolovirus , Anciano de 80 o más Años , Brasil , Exantema , Técnica del Anticuerpo Fluorescente Indirecta , Herpesvirus Humano 7 , Prevalencia , Infecciones por Roseolovirus , Estudios Seroepidemiológicos , Distribución por SexoRESUMEN
A total of 730 children aged less than 7 years, attending 8 day-care centers (DCCs) in Belém, Brazil were followed-up from January to December 1997 to investigate the occurrence of human-herpes virus 6 (HHV-6) infection in these institutional settings. Between October and December 1997 there have been outbreaks of a febrile- and -exanthematous disease, affecting at least 15-20 percent of children in each of the DCCs. Both serum- and- plasma samples were obtained from 401 (55 percent) of the 730 participating children for the detection of HHV-6 antibodies by enzyme-linked immunosorbent assay (ELISA), and viral DNA amplification through the nested-PCR. Recent HHV-6 infection was diagnosed in 63.8 percent (256/401) of them, as defined by the presence of both IgM and IgG-specific antibodies (IgM+/IgG+); of these, 114 (44.5 percent) were symptomatic and 142 (55.5 percent) had no symptoms (p = 0.03). A subgroup of 123 (30.7 percent) children were found to be IgM-/IgG+, whereas the remaining 22 (5.5 percent) children had neither IgM nor IgG HHV-6- antibodies (IgM-/IgG-). Of the 118 children reacting strongly IgM-positive ( > or = 30 PANBIO units), 26 (22.0 percent) were found to harbour the HHV-6 DNA, as demonstrated by nested-PCR. Taken the ELISA-IgM- and- nested PCR-positive results together, HHV-6 infection was shown to have occurred in 5 of the 8 DCCs under follow-up. Serological evidence of recent infections by Epstein-Barr virus (EBV) and parvovirus B19 were identified in 2.0 percent (8/401) and 1.5 percent (6/401) of the children, respectively. Our data provide strong evidence that HHV-6 is a common cause of outbreaks of febrile/exanthematous diseases among children attending DCCs in the Belém area
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Guarderías Infantiles , Brotes de Enfermedades , Exantema Súbito/epidemiología , Herpesvirus Humano 6/aislamiento & purificación , Anticuerpos Antivirales/sangre , Brasil/epidemiología , ADN Viral , Ensayo de Inmunoadsorción Enzimática , Exantema Súbito/sangre , Exantema Súbito/diagnóstico , Estudios de Seguimiento , Herpesvirus Humano 6/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Reacción en Cadena de la Polimerasa , Población UrbanaRESUMEN
Infecçöes sucessivas causadas por rotavírus foram detectadas em quatro crianças habitantes de Belém, acompanhadas desde seu nascimento até os três anos de idade. Em uma delas (Reg. 23.983) três infecçöes sintomáticas foram observadas, duas por sorotipo näo especificado e outra pelo 2: a primeira aos 4 meses, a segunda aos 20, e a terceira aos 27. Outro indivíduo (Reg. 24.384) apresentou dois episódios diarréico, com intervalo de oito meses, o primeiro sorotipo 1 e o segundo por sorotipo näo identificado. Infecçöes também aparentes foram observadas em duas ocasiöes envolvendo a mesma criança (Reg. 24.004), a primeira por sorotipo 1 e, doze meses após, uma segunda pelo 2. Em uma outra criança (Reg. 24.097) duas infecçöes, ambas inaparentes e por sorotipo näo especificado, foram detectadas: a primeira aos 24 meses de vida e a segunda, aos 28
Asunto(s)
Lactante , Preescolar , Humanos , Masculino , Femenino , Infecciones por Rotavirus/epidemiología , Antígenos Virales/análisis , Brasil , Estudios de Seguimiento , Recurrencia , Rotavirus/inmunologíaRESUMEN
Amostras de rotavírus provenientes de crianças habitantes na periferia de Belém, Pará, foram analisadas por eletroforese em gel de policrilamida (PAGE). As bandas correspondentes aos 11 segmentos de ARN foram detectadas em 46 (76,7%) das 60 amostras de rotavírus. Das amostras classificadas 5 (109%) foram relativas ao subgrupo I, 41 (89,1%) ao subgrupo II e, em 23,3%) näo foi possível classificaçäo face a ausência das bandas 10 e 11. As amostras de rotavírus sub-grupo II e codificadas como "1N2L" foram as mais freqüentes, ocorrendo em 30 (65,2%) das 46 classificadas
Asunto(s)
Niño , Humanos , Heces/microbiología , ARN Viral/análisis , Rotavirus/genética , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción EnzimáticaRESUMEN
Rotavírus atípicos foram detectados nas fezes de duas crianças diarreícas residentes em Belém, Brasil. Partículas de rotavírus foram visualizadas por microscopia eletrônica nos espécimes fecais de ambos os pacientes, tendo a eletroforese do ácido ribonucleico (ARN) exibido padröes compatíveis com rotavírus do grupo C. Testes imunoenzimáticos (ELISA) foram negativos quanto a presença de antígenos do grupo A. As duas crianças apresentaram três infecçöes sucessivas por esse agente, sendo que, em ambos os casos, os rotavírus atípicos foram excretados por ocasiäo da terceira infecçäo, produzindo sintomas brandos e de pouca duraçäo
Asunto(s)
Preescolar , Humanos , Masculino , Diarrea/etiología , Infecciones por Rotavirus/complicaciones , Rotavirus/aislamiento & purificación , Brasil , Heces/microbiología , Rotavirus/ultraestructuraRESUMEN
A total of 220 patients with arthropathy were selected in Belém, Pará between January 1994 and December 2000, and screened for the presence of human parvovirus B19 IgM and IgG antibodies by enzyme-linked immunosorbent assay (ELISA). A subgroup (n = 132) of patients with high levels of antibodies (either IgM+/IgG+ or IgM-/IgG+) were examined for the presence of DNA by polymerase chain reaction/nested PCR. Recent/active infection (detection of IgM and/or IgG-specific antibodies and presence of viral DNA) was identified in 47.7 percent of the 132 individuals with arthropathy. In our study, women were significantly more affected (59.7 percent) than men (35.4 percent) (P = 0.0006). The age group of 11-20 years (84.6 percent), among female patients, and 21-30 years (42.1 percent), among male, were those with the highest incidence rates. The analysis of the temporal distribution of B19-associated arthropaties showed a cyclic pattern, with peak incidence rates occuring at 3-5 year intervals. Significant diference (P = 0.01) was observed when comparing both the highest (39.0 percent) and the lowest (11.0 percent) seropositivity rates for the years of 1995 and 2000, respectively. The interfalangial joints of hands and feet were mostly affected, with 50.0 percent and 48.0 percent of cases among both women and men, respectively. In a smaller proportion, other joints such as those of knee, ankle, pulse and shoulder were affected. As for the duration, symptoms lasted 1 to 5 days in 54.0 percent of the individuals, whereas in 46.0 percent of them the disease lasted 6-10 days, if considered the subgroup (n = 63) of patients with recent/active infection by parvovirus B19. In our study, joint clinical manifestations occurred symmetrically. Our results indicate that B19 may be an important agent of arthropathies in our region, and this underscores the need for specific laboratory diagnosis when treating patients suffering from acute arthropathy, mainly pregnant women
Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Adulto , Anticuerpos Antivirales , Artropatías , Infecciones por Parvoviridae , Parvovirus B19 Humano , Brasil , ADN Viral , Ensayo de Inmunoadsorción Enzimática , Eritema Infeccioso , Inmunoglobulina G , Inmunoglobulina M , Artropatías , Infecciones por Parvoviridae , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Pruebas SerológicasRESUMEN
The rhesus-human reassortant, tetravalent rotavirus vaccine (RRV-TV) was licensed for routine use in the United States of America but it was recently withdrawn from the market because of its possible association with intussusception as an adverse event. The protective efficacy of 3 doses of RRV-TV, in its lower-titer (4 x 10(4) pfu/dose) formulation, was evaluated according to the nutritional status of infants who participated in a phase III trial in Belém, Northern Brazil. A moderate protection conferred by RRV-TV was related to weight-for-age Z-scores (WAZ) greater than -1 only, with rates of 38 percent (p = 0.04) and 40 percent (p = 0.04) for all- and- pure rotavirus diarrhoeal cases, respectively. In addition, there was a trend for greater efficacy (43 percent, p = 0.05) among infants reaching an height-for-age Z-score (HAZ) of > -1. Taking WAZ, HAZ and weight-for-height Z-score (WHZ) indices <= -1 together, there was no significant protection (p > 0.05) if both placebo and vaccine groups are compared. There was no significant difference if rates of mixed and pure rotavirus diarrhoeal cases are compared in relation to HAZ, WAZ and weight-for-height Z-score (WHZ) indices. Although a low number of malnourished infants could be identified in the present study, our data show some evidence that malnutrition may interfere with the efficacy of rotavirus vaccines in developing countries
Asunto(s)
Humanos , Animales , Recién Nacido , Lactante , Diarrea , Estado Nutricional , Rotavirus , Infecciones por Rotavirus , Vacunas contra Rotavirus , Vacunas Atenuadas , Antropometría , Brasil , Países Desarrollados , Diarrea , Método Doble Ciego , Gastroenteritis , Virus Reordenados , Vacunas contra Rotavirus , Vacunación , Vacunas Atenuadas , Vacunas CombinadasRESUMEN
Três episódios de infecçäo por rotavírus em uma única criança foram observados ao longo de um estudo prospectivo na área urbana de Belém, Pará, Brasil, no decorrer de seus primeiros vinte e sete meses de vida. A detecçäo do rotavírus, classificado como susbgrupo II, sorotipo näo determinado, foi obtida nas duas primeiras infecçöes, sucedendo-se uma terceira pelo subgrupo I, sorotipo 2. Nesses episódios observaram-se dois perfis eletroforéticos diferentes. A primeira infecçäo ocorreu aos 4 meses de vida e as seguintes nos 20§ e 27§ meses. Os processos infecciosos ocorreram de forma sintomática, sendo que em dois dos três episódios, as manifestaçöes clínicas foram severas; o segundo em maior grau que o primeiro e o terceiro mais benigno que os anteriores
Asunto(s)
Lactante , Humanos , Femenino , Infecciones por Rotavirus/epidemiología , Brasil , Infecciones por Rotavirus/microbiología , Estudios Prospectivos , RecurrenciaRESUMEN
Reinfecçöes por rotavírus foram detectadas em 7 (9,2%) de 76 crianças habitantes da periferia de Belém, Pará, Brasil, no decurso de seus primeiros 20 meses de vida. A presença de rotavírus classificados no subgrupo II ("long pattern") foi assinalada, tanta na primeira como segunda infecçöes, em cinco desses indivíduos. Em duas situaçöes, a primeira infecçäo foi causada por rotavírus subgrupo II e, a reinfecçäo, por rotavírus de subgrupo näo claramente caracterizado. Seis diferentes padröes foram observados, näo ocorrendo casos em que, numa única criança, se tenham assinalado perfis homólogos. O maior intervalo de tempo registrado entre duas infecçöes no mesmo indivíduo foi de 19 meses, enquanto que o menor, de 6. Formas sintomáticas em ambos os processos infecciosos se apresentaram em cinco crianças; em duas, os primeiros episódios revelaram-se assintomáticos, sucedendo-se quadros diarréicos. Em seis dos sete indivíduos, observaram-se soroconversöes para rotavírus durante a segunda infecçäo; durante a primeira, entretanto, a elevaçäo significativa nos níveis de anticorpos grupo-específicos se registrou em apenas um caso (Paciente F)
Asunto(s)
Recién Nacido , Lactante , Humanos , Masculino , Femenino , Infecciones por Rotavirus/epidemiología , Brasil , Genes Virales , Recurrencia , Infecciones por Rotavirus/complicaciones , Rotavirus/genéticaRESUMEN
Uma cepa de rotavírus, obtida de criança diarreica com 22 meses de idade, näo reagiu com anticorpos monoclonais para os quatro sorotipos desse agente, emergindo como um possível novo sorotipo. Essa amostra se caracterizou por pertencer ao subgrupo II, exibindo perfil genômico, por eletroforese em gel de policrilamida, tipicamente longo. Detectou-se, ainda, outra amostra de rotavírus, oriunda de criança com 19 meses de idade, assintomática, com características sorológicas que a classificaram como sorotipo 2, monoclonais. Näo se obtiveram padröes de eletroforese nucleica suficientemente nítidos, bem como näo se logrou a replicaçäo virótica dessa cepa em células da linhagem "MA 104", quer a partir da simples suspensäo de fezes, quer após efetuada a purificaçäo em gradiente de cloreto de césio. Ambos os achados acima referidos decorreram de estudo longitudinal envolvendo 88 crianças, habitantes da área periférica de Belém, observados desde o seu nascimento até os três anos de idade
Asunto(s)
Lactante , Humanos , Rotavirus/análisis , Diarrea Infantil/parasitología , Brasil , Estudios Longitudinales , Electroforesis en Gel de Poliacrilamida , Anticuerpos Monoclonales/análisisRESUMEN
Nine hundred and forty-eight serum samples from 83 children living in Belem, Brazil, collected within their first three years oflife, were tested for the presence of groupspecific rotavirus-antibody by an enzyme-linked immunosorbent assay (Elisa) blocking-test. Passively transferred maternal antibody lasted about two and half months; subsenquentely, low levels of rotavirus antibody started to appear at seven months, reaching a peak at eleven months of age. From one year onwards positivity gradually increased, reaching highest values at 34 months of life. Individual responses were examined in sera from 61 children who were followed up since birth to three years of age: 38 (62,3%) of them developed a long-term immunity following first infection; eleven (18.0%) children developed a short-term immunity after first infection by rotavirus; seven (11.5%) had no antibody response within their first three years of life; and 5 (8.2%) showed positive antibody response from birth to three years old